Novo Nordisk Way is our way

In 1923, our Danish founders began a journey to change diabetes.
Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. See the movie and get an idea of the Novo Nordisk Way

Read more

Novo Nordisk in short

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 41,500 employees in 75 countries, and markets its products in more than 180 countries.
Novo Nordisk’s B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

A passion for helping people

The story of Novo Nordisk goes back more than 80 years. It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.

Novo Nordisk's history

Our business philosophy

The Triple Bottom Line -
our way of doing business
We believe that a healthy economy, environment and society are fundamental to long-term business success. This is why we manage our business in accordance with the Triple Bottom Line business principle and pursue business solutions that maximise value to our stakeholders as well as our shareholders.

In practice, this means that any decision should always seek to combine three considerations: is it financially, socially and environmentally responsible? This way, we continuously optimise our business performance and enhance our contribution to the societies we operate in.

If you are more interested in our way of doing business, we suggest you read these pages:
Our priorities 
Our positions
Our reporting 
Or look here for further information on how we manage sustainably. 

Facts and figures


Affiliates or offices in 75 countries

Approximately 41,500 employees (December 2014)

Product areas
Diabetes Care
Haemostasis management
Growth hormone therapy
Hormone replacement therapy

General information
More facts and figures here


Corporate Headquarters
Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd

See our different locations and find a local office 

Welcome to the world of Novo Nordisk

Read our company brochure

Download centre

Download presentations, reports and magazines

Download centre